Cubist Systematic Strategies’s Arbutus Biopharma ABUS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-7,192
| Closed | -$18K | – | 2150 |
|
|
2023
Q4 | $18K | Buy |
+7,192
| New | +$18K | ﹤0.01% | 1944 |
|
|
2023
Q2 | – | Sell |
-119,193
| Closed | -$361K | – | 2213 |
|
|
2023
Q1 | $361K | Buy |
+119,193
| New | +$361K | ﹤0.01% | 1941 |
|
|
2022
Q4 | – | Sell |
-10,726
| Closed | -$20K | – | 3225 |
|
|
2022
Q3 | $20K | Sell |
10,726
-30,021
| -74% | -$56K | ﹤0.01% | 3439 |
|
|
2022
Q2 | $110K | Sell |
40,747
-154,717
| -79% | -$418K | ﹤0.01% | 3403 |
|
|
2022
Q1 | $582K | Sell |
195,464
-68,124
| -26% | -$203K | ﹤0.01% | 2416 |
|
|
2021
Q4 | $1.03M | Buy |
263,588
+249,988
| +1,838% | +$972K | 0.01% | 1895 |
|
|
2021
Q3 | $58K | Sell |
13,600
-50,100
| -79% | -$214K | ﹤0.01% | 2821 |
|
|
2021
Q2 | $193K | Sell |
63,700
-121,815
| -66% | -$369K | ﹤0.01% | 2577 |
|
|
2021
Q1 | $618K | Buy |
185,515
+134,616
| +264% | +$448K | 0.01% | 1839 |
|
|
2020
Q4 | $181K | Buy |
+50,899
| New | +$181K | ﹤0.01% | 2272 |
|
|
2020
Q3 | – | Sell |
-12,562
| Closed | -$23K | – | 2464 |
|
|
2020
Q2 | $23K | Buy |
+12,562
| New | +$23K | ﹤0.01% | 2310 |
|
|
2020
Q1 | – | Sell |
-895
| Closed | -$2K | – | 2128 |
|
|
2019
Q4 | $2K | Buy |
+895
| New | +$2K | ﹤0.01% | 2385 |
|
|
2017
Q4 | – | Sell |
-300
| Closed | -$2K | – | 1877 |
|
|
2017
Q3 | $2K | Buy |
+300
| New | +$2K | ﹤0.01% | 1810 |
|
|
2015
Q3 | – | Sell |
-1,634
| Closed | -$19K | – | 1838 |
|
|
2015
Q2 | $19K | Buy |
1,634
+1,534
| +1,534% | +$17.8K | ﹤0.01% | 1756 |
|
|
2015
Q1 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 1859 |
|